Anant Labs

Cefuroxime Axetil Dimer

Impurity

This molecule is a impurity of Cefuroxime Sodium.

Cefuroxime Axetil Dimer
In Stock

Impurity

Cefuroxime Axetil Dimer

Cat. No. ANTPRD14057CAS 1202925-10-7In StockSynthesized
Technical Data
Cat. No.ANTPRD14057
CAS1202925-10-7
Mol. FormulaC36H38N8O17S2
Mol. Weight918.873 g/mol
IUPAC1-[1-[(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbonyl]oxyethoxy]ethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SMILESCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OC(C)OC(C)OC(=O)C3=C(COC(N)=O)CS[C@@H]4[C@H](NC(=O)/C(=N\OC)c5ccco5)C(=O)N34)=C(COC(N)=O)CS[C@H]12)c1ccco1
InChIInChI=1S/C36H38N8O17S2/c1-15(60-33(49)25-17(11-57-35(37)51)13-62-31-23(29(47)43(25)31)39-27(45)21(41-53-3)19-7-5-9-55-19)59-16(2)61-34(50)26-18(12-58-36(38)52)14-63-32-24(30(48)44(26)32)40-28(46)22(42-54-4)20-8-6-10-56-20/h5-10,15-16,23-24,31-32H,11-14H2,1-4H3,(H2,37,51)(H2,38,52)(H,39,45)(H,40,46)/b41-21-,42-22-/t15?,16?,23-,24-,31-,32-/m1/s1
InChI KeyDZQZJSJRFYIIOK-IQJFPHHVSA-N
Description

Overview

Cefuroxime Axetil Dimer, Cefuroxime Sodium, 1202925-10-7, 1-[1-[(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbonyl]oxyethoxy]ethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Anant Labs is the renowned and Authentic Manufacturer and Supplier of Cefuroxime Axetil Dimer in India.

At Anant, we have expertise in synthetic organic chemistry and pharmaceutical analysis and we provide cost effective and accurate custom research services to the industry.

Synonyms

Di(cefuroxime Ethyl) EtherCefuroxime axetil dimer1-[1-[(6R,7R)-3-(Carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbonyl]oxyethoxy]ethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate2,2'-(Oxydiethylidene) bis((6R,7R)-3-(((aminocarbonyl)oxy)methyl)-7-(((2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate)5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-(((2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl)amino)-8-oxo-, 2,2'-(oxydiethylidene) ester, (6R,6'R,7R,7'R)-(6R,6'R,7R,7'R,Z)-Oxybis(ethane-1,1-diyl) bis(3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate) (Cefuroxime sodium Impurity)Di(cefuroxime Ethyl) Ether; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, 2,2'-(oxydiethylidene) ester, (6R,6'R,7R,7'R)-; 1-[1-[(6R,7R)-3-(Carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-